Could Your Weight Loss Medication Boost Your Brain Health? Concordia Study Seeks Participants

2025-05-25
Could Your Weight Loss Medication Boost Your Brain Health? Concordia Study Seeks Participants
InForum

Are you taking a GLP-1 receptor agonist medication like Ozempic or Wegovy for weight management? Concordia University is conducting groundbreaking research to explore whether these popular medications might also offer cognitive benefits for older adults. We're looking for participants to join our study and contribute to a better understanding of how lifestyle, medication, and brain health intersect.

About the Study

As Australia's population ages, maintaining cognitive health is becoming increasingly important. Recent research suggests that GLP-1 receptor agonists, initially developed for managing diabetes and now widely used for weight loss, may have a positive impact on cognitive function. This study aims to investigate this potential link further, examining the relationship between medication use, lifestyle factors (such as diet and exercise), and cognitive performance in adults aged 60 and over.

Who Can Participate?

We invite individuals who meet the following criteria to participate:

What's Involved?

Participation in the study involves several components:

Why Participate?

By participating in this study, you can:

Interested in Learning More?

If you're interested in learning more about the study or determining your eligibility, please contact the research team at [Insert Contact Email Address or Phone Number Here]. We’d love to hear from you!

Disclaimer: This study has been approved by the Concordia University Research Ethics Board. Your participation is voluntary, and you can withdraw at any time without penalty. All data will be kept confidential and used for research purposes only.

Recommendations
Recommendations